(PRESPEND) Prot #R475-OA-1815: Study to Evaluate Synovial Fluid in the Phase 3 Fasinumab Program for Osteoarthritis of the Knee and Hip

Project: Research project

Project Details

StatusFinished
Effective start/end date1/24/19 → 1/24/20

Funding

  • ICON Clinical Research Limited (Prot #R475-OA-1815 // Prot #R475-OA-1815)
  • Regeneron Pharmaceuticals, Inc. (Prot #R475-OA-1815 // Prot #R475-OA-1815)